chevron_leftBack
As of 10 July 2026, Roche Holding AG has a market cap of $317.27B USD, ranking #43 globally and #1 in Switzerland.
It ranks #5 in the Healthcare sector, and #4 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$317.27BUSD
256.25B CHF
Enterprise Value
$344.72BUSD
278.04B CHF
Revenue (TTM)
$78.44BUSD
63.36B CHF
EBITDA (TTM)
$29.81BUSD
24.04B CHF
Net Income (TTM)
$15.95BUSD
12.88B CHF
EBITDA Margin
38%
Profit Margin
20%
PE Ratio
19.9
Forward PE
15.6
PS Ratio
4.0
PB Ratio
6.8
EV/EBITDA
11.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Thomas Schinecker
open_in_new
Employees
103,249
Founded
1896
Website
roche.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.4% | 1.2% | 1.4% | -5.4% | 20% | 15% |
Upcoming Earnings
Earnings Date
Thu, Jul 23
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
RO
Roche Holding AG Bearer Shares
ISIN: CH0012032113
Shares Out.:
Shares Outstanding:
106.691M1
Shares Float:
29.541M2
|
323.80 CHF | |
|
ROG
ISIN: CH0012032048
Shares Out.:
Shares Outstanding:
688.927M1
Shares Float:
688.884M2
|
322.30 CHF | |
|
ROP
ISIN: CH1499059983
Shares Out.:
Shares Outstanding:
688.927M1
Shares Float:
688.927M2
|
317.30 CHF |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Roche Holding AG
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SIX: NOVN
|
$271.02B
-15%
218.9B CHF
|
20.5
|
|
SIX: GALD
|
$45.96B
-86%
37.12B CHF
|
77.4
|
|
SIX: SDZ
|
$33.57B
-89%
27.11B CHF
|
37.8
|
|
SSE: 688235
|
$32.48B
-90%
220.98B CNY
|
110.1
|
|
SIX: BANB
|
$6.32B
-98%
5.11B CHF
|
34.3
|
|
SIX: SFZN
|
$4.16B
-99%
3.36B CHF
|
20.0
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
140%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
72%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
14%
|
97.4
|
|
LSE: AZN
|
$288.88B
-8.9%
215.59B GBP
|
27.6
|
|
NYSE: MRK
|
$274.03B
-14%
|
15.1
|
|
CPH: NOVO-B
|
$179.7B
-43%
1.18T DKK
|
11.5
|
chevron_leftBack